Antibiotic-resistant bacteria in donor human milk: KGMU docs raise concern
Tired of too many ads? go ad free now
The study, carried out at KGMU's donor human milk bank, was published in the International Journal of Medical Microbiology in Jan.
It was discussed during World Breastfeeding Week, celebrated from Aug 1 to 7.
Researchers said that the milk collected at KGMU is properly treated before being given to infants, but the study shows that all milk banks across the country must follow similar safety practices.
The study, titled, 'Microbial Profiling, Antimicrobial Resistance Surveillance, and Molecular Detection of MecA Gene in Staphylococcal Strains from Donor Human Milk: Insights from a Milk Bank Investigation,' was led by Prof Sheetal Verma from the microbiology department.
Her team tested 151 samples of donated human milk. Out of these, 58 samples had no germs at all, which is good news. However, 93 samples (61%) did contain bacteria.
Among these, 54 had Gram-positive bacteria, and 39 had Gram-negative bacteria.
The most common type of bacteria found was Staphylococcus, seen in 49 samples. Other bacteria included Acinetobacter (20 samples), Pseudomonas (9), Enterococcus (5), and Klebsiella.
Prof Verma said that while pasteurisation (a process of heating milk to kill germs) removes many harmful bacteria, some that are resistant to antibiotics may survive.
This means strict hygiene and regular testing are very important.
She also pointed out that if donor mothers take antibiotics frequently, it can lead to antibiotic-resistant bacteria being present in their milk.
Dr Astha Yadav, a co-researcher, added that since donor milk is often used for premature and very sick babies, it must be checked thoroughly before use.
The research team also included Prof Vimala Venkatesh, Prof Amita Jain, Prof Mala Kumar, Dr Saurabh Kashyap, and Dr Shalini Tripathi.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
From Silent Suffering to Sleep Recovery: How Healthy Jeena Sikho is Changing the
India stands at the crossroads of a looming healthcare crisis, one that hides in bedrooms, behind closed doors, wrapped in silence and exhaustion. Every night, millions unknowingly endure the perils of sleep apnea and other chronic respiratory conditions, quietly suffering as symptoms escalate from mild fatigue to life-threatening disease. Yet, change is sweeping through Indian homes, driven not by doctors in white coats alone, but by visionary entrepreneurs who know what it means to care for a loved one. A Mission Inspired by Personal Journeys Saket Agarwal and Jatinder Verma were once united by the zeal and success typical of India's corporate elite, Agarwal as Global CEO at Spice Group, Verma steering technology for a Indian Railway BPO. Yet their defining moment came far from boardrooms, in the daunting corridors of hospitals, attending to their mothers' health struggles. This intimate encounter with India's fragmented home healthcare landscape sparked a realization: millions silently battled respiratory issues with scant awareness or access to solutions. This drove Agarwal and Verma to found Healthy Jeena Sikho (HJS), a company built not solely for commercial success but from a deep commitment to democratize respiratory and home healthcare across India. Today, HJS has evolved from a startup renting medical equipment to a comprehensive health platform that has reached over one lakh (100,000+) families, a testament to scale, impact, and trust. Unmasking India's Sleep Crisis: Facts You Can't Ignore While respiratory problems abound, obstructive sleep apnea (OSA) stands out as both widespread and underdiagnosed. Globally, about 1 billion people suffer from sleep apnea. In India, studies suggest between 10–14% of adults, often cited as 100 million+ Indians, may be affected. Yet what's truly alarming is how many cases go unnoticed: - Only 2–4% of those affected ever seek medical help - Prevalence among males can reach up to 19.7%, about double that of females Children aren't spared either—studies in Andhra Pradesh revealed 5.7% of school children aged 6–12 had OSA, underscoring a pan-India, all-age concern. Sleep apnea's effects go far beyond snoring or daytime fatigue. Left untreated, OSA raises risks of: - Hypertension: 2–3 times higher - Type 2 Diabetes: Present in 70% of moderate-to-severe cases - Stroke: 2–4 times higher likelihood - Early cognitive decline, depression, metabolic syndrome Despite these risks, Indian households often dismiss symptoms as mere tiredness, unwittingly letting a silent epidemic deepen. Sleep Apnea in India: Key Stats at a Glance - 100 million+ adults likely affected (10–14% prevalence) - 80–90% never diagnosed - Risks include heart disease, diabetes, stroke, depression - Women, children, seniors also vulnerable - Sleep study tests in hospitals often cost ₹15,000– ₹25,000, out of reach for most The Power and Value of Early Diagnosis Identifying sleep apnea early is nothing short of a lifesaver. According to both national and international research: - Early detection and CPAP therapy halt or reverse cardiovascular strain, lower blood pressure, and restore oxygen to the brain. - Quality sleep improves memory, mood, and productivity, studies show cognitive performance can improve by up to 30%. - Timely intervention cuts long-term costs of chronic disease management and avoids costly hospitalizations. - Improved well-being is visible within weeks, patients report better energy, normalized blood pressure, and renewed zest for life. Without early diagnosis, untreated sleep apnea may slowly escalate, demanding lifelong medical intervention and drastically raising healthcare costs. Breaking Barriers: Healthy Jeena Sikho's Solution Having served one lakh families, HJS saw a telling pattern, many patients needing oxygen concentrators, BiPAP, or CPAP had never been formally diagnosed. Whether due to lack of awareness, high cost, or limited sleep clinic access, the problem persisted. India's response? HJS launched the first ₹999 sleep study at home. Instead of costly, intimidating hospital stays, this at-home test offered professional-grade diagnosis, affordable, convenient, and accurate. Patients could sleep in their own bed and receive expert analysis, breaking a long-standing barrier to care. Thousands have since taken the test, many discovering their fatigue, memory issues, and blood pressure were not separate problems, but symptoms of severe sleep apnea. The Human Side: Priya's Transformation Consider Priya Sharma, 52, a homemaker in Delhi. For years, her family dismissed her headaches and irritability; snoring was the nightly background noise. When HJS launched the ₹999 sleep study, Priya's daughter insisted she try it. The verdict was clear, severe OSA. Within 48 hours, HJS provided a CPAP machine, personal mask fitting, and usage training. In just three months, Priya saw her blood pressure normalize, reported better sleep, and felt years younger. Now, her entire family is more aware and proactive about sleep health. A Business Model Built on Trust and Scale What makes HJS stand out isn't just its innovative diagnosis; it's the company's one-stop healthcare platform: - Comprehensive Rentals: Hospital beds, BiPAP/CPAP devices, oxygen concentrators, wheelchairs—all delivered quickly and maintained professionally - Rapid Response: Same-day delivery in key cities, thanks to regional warehouses and ready stock - Expert Support: Trained respiratory technicians, not generic delivery staff; live 24x7 helpline support - Doctor Partnerships: Growing network of referring GPs and pulmonologists, ensuring continuity of care - Quality Assurance: Partnerships with leading global brands are ResMed, Philips, Oxymed, BMC, promise safe and effective solutions Presence and Impact: - Serving 15+ cities with pan-India delivery - Over 100,000 families cared for - Consistent 5-star Google ratings and a 35% customer referral rate, clear markers of trust and loyalty Data-Driven Approach and Societal Impact HJS's commitment to data goes beyond numbers. When founders found that 20% of senior business leaders in their network needed urgent respiratory support, it signalled a deeper crisis affecting even the most health-aware groups. Moreover, a striking 35% recurrence rate among respiratory device users pointed to chronic, under-managed conditions and highlighted the need for ongoing care and health literacy. HJS responded with digital outreach—blogs, videos, and campaigns that have reached 1.5 million+ viewers, raising public awareness while empowering families to seek answers. Redefining Healthcare for India's Future India is forecasted to double its senior citizen population by 2050, with non-communicable diseases on the rise. Hospitals alone cannot absorb this strain. Companies like HJS are building parallel, scalable healthcare infrastructure, empowering homes to become frontline care centers, not just end-points. From affordable sleep studies to empathetic post-diagnosis service, HJS sets a benchmark—proving that prevention, convenience, and compassion can drive better health outcomes for everyone. 'We started with rentals,' Agarwal reflects. 'But now we're driving a movement for accessible, preventive healthcare—one home, one family at a time.' The Sound of Renewal The soft hum of a CPAP machine in households across India is not just a sign of illness, it is the melody of renewed health, dignity, and hope. Each restful night achieved marks a quiet victory against an epidemic hidden in plain sight. Healthy Jeena Sikho, by blending technological innovation, empathetic service, and community education, isn't just supporting recovery—it's restoring lives. For more information, media inquiries, or to book a home sleep study: 📩 info@ 🌐 Disclaimer: This article is sponsored content curated by HT Syndication. The inputs and details accounted for in the article do not necessarily reflect those of HT, and HT does not endorse or assume any responsibility for the information provided. Want to get your story featured as above? click here!
Time of India
6 hours ago
- Time of India
High microbial contamination in herbal drugs, says ICMR-NIN study
Hyderabad: A microbiological risk assessment by the Indian Council of Medical Research's National Institute of Nutrition found that a majority of herbal formulations sold in Hyderabad contain bacterial contamination exceeding US Pharmacopoeia's permissible limits. The study, led by Surekha Mullapudi Venkata from the Pathology and Microbiology Division of NIN, analysed 170 herbal products and found that 52.4% were non-compliant with the standards. The study revealed that solid herbal formulations recorded the highest contamination levels, with 63.6% of the 110 solid samples exceeding aerobic bacterial limits. The research was published on August 5 in Science Direct's Journal of Herbal Medicine under the title "Microbiological Risk Assessment and Safety Evaluation of Widely Used Herbal Pharmaceuticals". The study found pathogens including Escherichia coli, faecal coliforms, Staphylococcus, Pseudomonas, Salmonella, yeast, and moulds in herbal formulations. Risk assessment using the Risk Ranger tool assigned the highest ranking of 75 to solid drugs, followed by semi-solids and liquids at 72 and 70, respectively. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad | Gold Rates Today in Hyderabad | Silver Rates Today in Hyderabad Findings and Health Implications NIN researchers conducted market surveys across the five zones of Greater Hyderabad Municipal Corporation to identify frequently consumed herbal products. Samples were collected from retail outlets in GHMC area using random sampling and tested according to US-FDA Bacteriological Analytical Manual methods. Among the 110 solid samples, 96.4% had total viable counts. Viable count is a method used in cell culture to determine the number of living cells in the culture. Staphylococcus, which causes multiple infections in humans, was detected in 62.7%, faecal coliforms in 32.7%, Pseudomonas in 31.8%, E coli in 5.5%, and yeast and moulds in 84.6% of samples. Semi-solid herbal formulations showed 63.3% total viable counts, with Staphylococcus in 30% and yeast and moulds in 23.3%. Liquid herbal drugs had 23.3% total viable counts, with yeast and moulds detected in 10%. Specific solid products with 100% non-compliance included Ashwagandha powder, Shatavari powder, Shatavari tablet, Brahmi powder, Trikatu powder, Dry ginger powder, and Yashtimadhu powder. Meanwhile, Tanikaya powder, Lodhra bark powder, Triphala powder, Ashwagandha tablet, Amla powder, Triphala tablet, and Karakaya powder showed non-compliance rates for US Pharmacopoeia standards ranging from 25% to 75%. The scientists warned that consumption of contaminated formulations could cause gastrointestinal illnesses and severe infections. The researchers recommended to the govt to bring in strict regulatory guidelines and quality monitoring in the manufacturing and storage of herbal drugs. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
Time of India
a day ago
- Time of India
Rehab unit for cerebral palsy kids at KGMU
Lucknow: A modern rehabilitation unit will be open in KGMU in paediatric orthopaedics department to provide complete care for children with cerebral palsy next week. KGMU vice chancellor Soniya Nityanand approved the project last year with a budget of Rs 30 lakh. Tired of too many ads? go ad free now The centre will focus on both recovery after surgery and treatment without surgery. It will bring together therapy, physiotherapy, occupational training and skill development for children in one place, ensuring continuous care. Cerebral palsy is a lifelong condition that affects movement and posture. It occurs due to abnormal brain development or brain damage before, during, or shortly after birth. Children with this condition may have muscle stiffness, weakness, involuntary movements, or problems with balance and coordination. Some children may also face speech, vision, learning, or other challenges, said Dr Syed Faisal Afaque, in charge of the Cerebral Palsy Unit. Department head Prof Vikas Verma said the new unit will benefit children from UP and neighbouring states, making KGMU a major centre for paediatric orthopaedic rehabilitation in North India. This new centre will help children move from surgery towards independent living, added Dr Suresh Chand, another faculty member.
